<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="FR" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>XM-DAC-41114-OUTPUT-00128541</iati-identifier>
  <reporting-org ref="XM-DAC-41114" type="40">
   <narrative xml:lang="FR">United Nations Development Programme</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">GF - C19RM 2021</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">GF C19RM 2021 - The goal is to decrease mortality and morbidity related to COVID in Guinea Bissau and to support the health system to respond to the pandemic.</narrative>
  </description>
  <participating-org ref="XM-DAC-47045" role="1">
   <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-47045" role="1" type="0">
   <narrative xml:lang="FR">TAR - The Global Fund to Fight</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41114" role="4" type="40">
   <narrative xml:lang="FR">United Nations Development Programme</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-01-01" type="1"></activity-date>
  <activity-date iso-date="2021-01-01" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <email>registry.gw@undp.org</email>
   <website>http://www.gw.undp.org/</website>
  </contact-info>
  <activity-scope code="8"></activity-scope>
  <recipient-country code="GW" percentage="100">
   <narrative xml:lang="FR">Guinea-Bissau</narrative>
  </recipient-country>
  <location ref="GW">
   <location-reach code="1"></location-reach>
   <location-id code="2374775" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="FR">Bissau</narrative>
   </name>
   <description>
    <narrative xml:lang="FR">capital of a political entity</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="FR">Guinea Bissau, whole country.</narrative>
   </activity-description>
   <administrative code="2374775" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>11.863570 -15.597670</pos>
   </point>
   <exactness code="1"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPLC"></feature-designation>
  </location>
  <sector code="18" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Accelerate structural transformations</narrative>
  </sector>
  <sector code="1.B" percentage="50" vocabulary="8"></sector>
  <sector code="12.7" percentage="50" vocabulary="8"></sector>
  <sector code="41010" percentage="100" vocabulary="1"></sector>
  <tag code="1.B" vocabulary="3"></tag>
  <tag code="12.7" vocabulary="3"></tag>
  <policy-marker code="1" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-12-31">1095250</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-05-31">1474125</value>
  </budget>
  <budget status="1" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-05-31">130625</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1095250</value>
   <provider-org ref="XM-DAC-47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00128541" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">1474125</value>
   <provider-org ref="XM-DAC-47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00128541" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">130625</value>
   <provider-org ref="XM-DAC-47045" type="0">
    <narrative xml:lang="FR">TAR - The Global Fund to Fight</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00128541" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">274051</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">31074</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-02-28"></transaction-date>
   <value currency="USD" value-date="2022-02-28">36365</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-03-31"></transaction-date>
   <value currency="USD" value-date="2022-03-31">49744</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">23997</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">1779250</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">13925</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-06-15"></transaction-date>
   <value currency="USD" value-date="2022-06-15">-1056</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <document-link format="TEXT/HTML" url="http://open.undp.org/projects/00130819">
   <title>
    <narrative xml:lang="FR">Activity web page</narrative>
   </title>
   <category code="A12"></category>
  </document-link>
  <related-activity ref="XM-DAC-41114-OUTPUT-00124029" type="3"></related-activity>
  <related-activity ref="XM-DAC-41114-PROJECT-00130819" type="1"></related-activity>
  <conditions attached="1">
   <condition type="1">
    <narrative xml:lang="FR">Social and environmental sustainability will be enhanced through application of the UNDP Social and Environmental Standards (http://www.undp.org/ses) and related Accountability Mechanism (http://www.undp.org/secu-srm).</narrative>
   </condition>
   <condition type="1">
    <narrative xml:lang="FR">UNDP as the Implementing Partner will comply with the policies, procedures and practices of the United Nations Security Management System (UNSMS.)</narrative>
   </condition>
  </conditions>
  <result aggregation-status="1" type="1">
   <title>
    <narrative xml:lang="FR">Annual Output Results</narrative>
   </title>
   <indicator ascending="0" measure="1">
    <title>
     <narrative xml:lang="FR">Output Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="FR">This project addresses the third SDG: Goal 3. Ensure healthy lives and promote well-being for all at all ages.

More specifically, it responds to following indicator from the Global Indicator Framework:
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

3.3.3 Malaria incidence per 1,000 population

Output Indicators
1.1 proportion of the population at risk potentially covered by the distribution of long-lasting insecticide-treated mosquito nets
1.2 Number of long-lasting insecticide-treated nets distributed continuously to target risk groups
1.3 Proportion of targeted risk groups receiving long-lasting insecticide-treated mosquito nets
1.4 Proportion of outbreaks in targeted areas that benefited from indoor residual spraying during the reporting period
2.1 Proportion of suspected malaria cases tested for parasitological testing in public sector health facilities
2.2 Proportion of suspected cases of malaria subjected to parasitological testing in the community
2.3 Proportion of suspected cases of malaria subjected to parasitological testing in private sector premises
3.1 Proportion of confirmed malaria cases receiving first-line antimalarial treatment in accordance with national policy in public sector health facilities
3.2  Proportion of confirmed malaria cases receiving first-line antimalarial treatment in accordance with national policy in the community
3.3 Proportion of confirmed malaria cases receiving first-line antimalarial treatment, in accordance with national policy, in private sector premises
3.4 Proportion of estimated malaria cases (suspected and confirmed) receiving first-line antimalarial treatment in public sector health facilities
3.5 Proportion of estimated malaria cases (suspected and confirmed) receiving first-line antimalarial treatment in the community
3.6 Proportion of estimated malaria cases (suspected and confirmed) receivin</narrative>
    </description>
    <baseline year="2021">
     <comment>
      <narrative xml:lang="FR">VC-3(M): Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution
-71093

CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
-100%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
-98.5%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
-91.1%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
-98.7%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
-73.6%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
-79.9%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
-10.2%

SPI-2: Percentage of children aged 3&#x2013;59 months who received the full number of courses of SMC (3 or 4) per  transmission season in the targeted areas
-84.6%

M&amp;E-2: Proportion of facility reports received over the reports expected during the reporting period
-78.5%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
-90.8

Baseline
1.1 proportion of the population at risk potentially covered by the distribution of long-lasting insecticide-treated mosquito nets	93.9%
1.2 Number of long-lasting insecticide-treated nets distributed continuously to target risk groups	101.417
1.3 Proportion of targeted risk groups receiving long-lasting insecticide-treated mosquito nets	NA
1.4 Proportion of outbreaks in targeted areas that benefited from indoor residual spraying during the reporting period	NA
2.1 Proportion of suspected malaria cases tested for parasitological testing in public sector health facilities	98.6%
2.2 Propor</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">1,219,145 long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution


CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
100.00%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
98.50%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
91.10%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
98.70%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
73.60%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
79.90%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
10.20%

M&amp;E-2: Proportion of facility reports received over the reports expected during the reporting period
78.50%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
90.80%

92.00%</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="FR">2019 S1

47,895 long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution
CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
97.48%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
92.55%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
99.4%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
94.7%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
76.6%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
97.3%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
43.7%

M&amp;E-1: Proportion of facility reports received over the reports expected during the reporting period
94.5%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
88.48%


2019 S2

53,522 long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution
CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
98%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
99.3%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
98.5%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
93.9%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
88.98%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
88.28%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
50.51%

M&amp;E-1: Proportion of facility reports received over the reports expected during the reporting period
98.34%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
93.87%</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">51,600 long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution


CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
100.00%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
98.50%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
91.10%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
98.70%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
73.60%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
79.90%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
10.20%

M&amp;E-2: Proportion of facility reports received over the reports expected during the reporting period
78.50%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
90.80%

92.00%</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="FR">2019 S1

47,895 long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution
CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
97.48%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
92.55%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
99.4%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
94.7%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
76.6%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
97.3%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
43.7%

M&amp;E-1: Proportion of facility reports received over the reports expected during the reporting period
94.5%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
88.48%


2019 S2

53,522 long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution
CM-1a(M): Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities
98%

CM-1b(M): Proportion of suspected malaria cases that receive a parasitological test in the community
99.3%

CM-1c(M): Proportion of suspected malaria cases that receive a parasitological test at private sector sites
98.5%

CM-2a(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities
93.9%

CM-2b(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community
88.98%

CM-2c(M): Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites
88.28%

SPI-1: Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria
50.51%

M&amp;E-1: Proportion of facility reports received over the reports expected during the reporting period
98.34%

CM-4: Proportion of health facilities without stock-outs of key commodities during the reporting period
93.87%</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
